about
Genome wide identification of recessive cancer genes by combinatorial mutation analysis.Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study.Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.Factors influencing success of clinical genome sequencing across a broad spectrum of disordersCombination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications.Reproductive decision-making in young female carriers of a BRCA mutation.Exploring the potential duty of care in clinical genomics under UK law.Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene.Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study.Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives."Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project.Communicating genetics research results to families: problems arising when the patient participant is deceasedFrom Genotype to PhenotypeAnalysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yieldDo health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease
P50
Q33375045-C1F4C70B-899E-48F7-A6EF-BD9E588B435DQ33665907-6C2C867E-6AB8-4D08-A29B-D174498461D8Q33737044-3A5A983B-45DC-4E02-B969-09DEAA1EE8C0Q35603662-C23ED837-45D8-463C-AA56-B7DB099B043FQ36147983-354867D7-0BA7-499F-8209-CDABF6EA5687Q37346547-C4CD7737-E65C-4E7D-9EFF-0169232E4D39Q37397650-2930877E-807D-449A-8BC7-4FC1B01B2931Q39490763-2C2D5D75-3CA4-4878-B1C2-0245B57BE55FQ41716228-D68BDBFC-39B9-4B6B-960D-883CDC0880E3Q48077724-C2905440-FBBA-42D9-93FA-0A9B85987834Q50025441-8A3F1F5D-7E2A-4378-8CE7-70ECA8BE25CFQ51730904-EAF82033-DA10-45B3-B657-1026A116FCABQ51986347-78494C23-2BC6-42EB-A8AB-C505ACBE3E55Q55112941-410F85A6-26BC-4AAC-9668-3E6307CD9E7AQ57694475-8739A8D6-8176-4C57-A535-EEFCF6FB22B5Q57818778-C97665CE-7E0B-440F-9511-71BB1D6F9AD1Q64042140-DFFF0C4B-66CF-48F8-9A1F-0608D4318369Q92667993-A6CBD8CC-3D19-418E-881F-59E4230173A3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elizabeth Ormondroyd
@ast
Elizabeth Ormondroyd
@en
Elizabeth Ormondroyd
@es
Elizabeth Ormondroyd
@nl
type
label
Elizabeth Ormondroyd
@ast
Elizabeth Ormondroyd
@en
Elizabeth Ormondroyd
@es
Elizabeth Ormondroyd
@nl
prefLabel
Elizabeth Ormondroyd
@ast
Elizabeth Ormondroyd
@en
Elizabeth Ormondroyd
@es
Elizabeth Ormondroyd
@nl
P106
P21
P31
P496
0000-0002-9116-4064